A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses
Open Access
- 28 September 2022
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-22
Abstract
CGAS-STING pathway is a key DNA-sensing machinery and emerges as a promising target to overcome the immunoresistance of solid tumors. Here we describe a bovine serum albumin (BSA)/ferritin-based nanoagonist incorporating manganese (II) ions and β-lapachone, which cooperatively activates cGAS-STING signaling in dendritic cells (DCs) to elicit robust adaptive antitumor immunity. Mn2+-anchored mannose-modified BSAs and β-lapachone-loaded ferritins are crosslinked to afford bioresponsive protein nanoassemblies, which dissociate into monodispersive protein units in acidic perivascular tumor microenvironment (TME), thus enabling enhanced tumor penetration and spatiotemporally controlled Mn2+ and β-lapachone delivery to DCs and tumor cells, respectively. β-lapachone causes immunogenic tumor cell apoptosis and releases abundant dsDNA into TME, while Mn2+ enhances the sensitivity of cGAS to dsDNA and augments STING signaling to trigger downstream immunostimulatory signals. The cGAS-STING nanoagonist enhances the tumor-specific T cell-mediated immune response against poorly immunogenic solid tumors in vivo, offering a robust approach for immunotherapy in the clinics.Keywords
This publication has 58 references indexed in Scilit:
- Acquired resistance to immunotherapy and future challengesNature Reviews Cancer, 2016
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and ImmunityCell Reports, 2015
- IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasisNature, 2015
- Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patientsNature, 2015
- The cGAS-STING Pathway for DNA SensingMolecular Cell, 2013
- cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STINGNature, 2013
- Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 2012
- HMGB1: A multifunctional alarmin driving autoimmune and inflammatory diseaseNature Reviews Rheumatology, 2012
- Lymphoid tissue–specific homing of bone marrow–derived dendritic cellsBlood, 2009
- Superoxide Dismutases in the Lung and Human Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2003